Dysgeusia and taste alterations (TAs) are side effects of cytotoxic chemotherapy and affect patients' quality of life; however, the prevalence, types, and duration of TAs and their potential relationship with other clinical disturbances are not well-described. Our primary aim was to prospectively evaluate the characteristics of TAs in early breast cancer (EBC) patients during (neo)adjuvant chemotherapy and up to 1 year after its completion.
Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study
Pedersini, Rebecca;Zamparini, Manuel;Bosio, Sara;di Mauro, Pierluigi;Turla, Antonella;Monteverdi, Sara;Amoroso, Vito;Cosentini, Deborah;Grisanti, Salvatore;Simoncini, Edda Lucia;Berruti, Alfredo
2022-01-01
Abstract
Dysgeusia and taste alterations (TAs) are side effects of cytotoxic chemotherapy and affect patients' quality of life; however, the prevalence, types, and duration of TAs and their potential relationship with other clinical disturbances are not well-described. Our primary aim was to prospectively evaluate the characteristics of TAs in early breast cancer (EBC) patients during (neo)adjuvant chemotherapy and up to 1 year after its completion.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2022 May - Taste alterations during neoadjuvant chemotherapy and subsequent follow-up in breast cancer patients a prospective single-center clinical study.pdf
solo utenti autorizzati
Tipologia:
Full Text
Licenza:
DRM non definito
Dimensione
767.73 kB
Formato
Adobe PDF
|
767.73 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
